HUP2000144A1 - Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálása - Google Patents
Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálásaInfo
- Publication number
- HUP2000144A1 HUP2000144A1 HU2000144A HUP2000144A HUP2000144A1 HU P2000144 A1 HUP2000144 A1 HU P2000144A1 HU 2000144 A HU2000144 A HU 2000144A HU P2000144 A HUP2000144 A HU P2000144A HU P2000144 A1 HUP2000144 A1 HU P2000144A1
- Authority
- HU
- Hungary
- Prior art keywords
- bps
- medicinal
- formulation
- pharmaceutical composition
- pain syndrome
- Prior art date
Links
- 208000005615 Interstitial Cystitis Diseases 0.000 title 2
- 230000003113 alkalizing effect Effects 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002485 urinary effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU2000144A HUP2000144A1 (hu) | 2020-04-29 | 2020-04-29 | Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálása |
EP21742476.1A EP4142700A1 (en) | 2020-04-29 | 2021-04-29 | Urinary alkalizing medicinal and/or pharmaceutical composition for the oral treatment of interstitial cystitis / bladder pain syndrome (ic/bps) and formulation thereof |
PCT/HU2021/000004 WO2021220022A1 (en) | 2020-04-29 | 2021-04-29 | Urinary alkalizing medicinal and/or pharmaceutical composition for the oral treatment of interstitial cystitis / bladder pain syndrome (ic/bps) and formulation thereof |
US17/922,221 US20230165822A1 (en) | 2020-04-29 | 2021-04-29 | Urinary alkalizing medicinal and/or pharmaceutical composition for the oral treatment of interstitial cystitis / bladder pain syndrome (ic/bps) and formulation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU2000144A HUP2000144A1 (hu) | 2020-04-29 | 2020-04-29 | Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálása |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP2000144A1 true HUP2000144A1 (hu) | 2022-04-28 |
Family
ID=89993112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU2000144A HUP2000144A1 (hu) | 2020-04-29 | 2020-04-29 | Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálása |
Country Status (4)
Country | Link |
---|---|
US (1) | US20230165822A1 (hu) |
EP (1) | EP4142700A1 (hu) |
HU (1) | HUP2000144A1 (hu) |
WO (1) | WO2021220022A1 (hu) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1708722T3 (da) * | 2004-01-28 | 2014-08-25 | Univ California | Ny interstitiel terapi til øjeblikkelig symptomlindring og kronisk terapived interstitiel cystit |
JP2006045200A (ja) * | 2004-06-28 | 2006-02-16 | Toru Araki | 間質性膀胱炎の治療薬 |
CN106038523B (zh) * | 2016-06-30 | 2019-11-12 | 安徽恒星制药有限公司 | 一种枸橼酸钾枸橼酸钠片及其制备方法 |
-
2020
- 2020-04-29 HU HU2000144A patent/HUP2000144A1/hu unknown
-
2021
- 2021-04-29 US US17/922,221 patent/US20230165822A1/en active Pending
- 2021-04-29 WO PCT/HU2021/000004 patent/WO2021220022A1/en unknown
- 2021-04-29 EP EP21742476.1A patent/EP4142700A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20230165822A1 (en) | 2023-06-01 |
WO2021220022A1 (en) | 2021-11-04 |
EP4142700A1 (en) | 2023-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020008258A (es) | Formulaciones pediátricas de niraparib y métodos de tratamiento pediátricos. | |
EP4110325A4 (en) | TRANSDERMAL AND/OR TOPICAL PHARMACEUTICAL FORMULATIONS CONTAINING CANNABIDIOL AND/OR TETRAHYDROCANNABINOL FOR THE TREATMENT OF CHRONIC PAIN | |
WO2015074045A3 (en) | Therapeutic delivery catheter with imaging and tissue characterization | |
EP1558220A4 (en) | ORAL COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
EP2392363A3 (en) | Drug coated expandable devices | |
MX2023010328A (es) | Composiciones de medicamentos a base de peptido de colageno y metodos y dispositivos para su produccion y uso. | |
EP4309722A3 (en) | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract | |
MX2009012054A (es) | Metodos de tratamiento que usan formulaciones intravenosas que comprenden temozolomida. | |
HUP2000144A1 (hu) | Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálása | |
IL299845A (en) | Oral unit dose compounds consisting of ibuprofen and famotidine for the treatment of acute pain and to reduce the severity and/or risk of heartburn | |
EP3909576A4 (en) | USE OF CHLOROGENIC ACID IN THE PREPARATION OF A MEDICINE OR A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF PAIN | |
EP3818981C0 (en) | SYNERGISTIC PHARMACEUTICAL COMPOSITION OF THE ACTIVE ENANTIOMER (S)-KETOROLAC AND GABAPENTIN FOR THE TREATMENT OF NEUROPATHIC PAIN | |
EP3737381A4 (en) | MEDICAL DEVICE AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF AN EYE DISEASE OR DISEASE | |
IL281513A (en) | Preparations for the treatment of joint pain | |
MX2024001832A (es) | Nueva composicion farmaceutica oral para terapias contra el cancer. | |
Telang | Body art: intraoral tattoos | |
EP3996655A4 (en) | MEDICAL DEVICES FOR TREATING DENTAL DISEASES AND METHODS FOR TREATING DENTAL DISEASES | |
EP4079281A4 (en) | ANTI-INFLAMMATORY LIQUID COMPOSITION FOR COVERING THE BUCCAL MUCOSA, AND MEDICINAL COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF STOMATITIS USING THE SAME | |
EP3838270A4 (en) | SYNERGISTIC PHARMACEUTICAL COMPOSITION WITH ACECLOFENAC AND BETAMETHASONE FOR THE TREATMENT OF PAIN IN LOCALIZED FORMS OF RHEUMATIC DISEASES | |
CN105267817A (zh) | 固泉脐贴 | |
AU2021381054A9 (en) | Pharmaceutical compositions for use in the management and treatment of pain | |
HUP0203065A2 (hu) | Nitrogén-oxid alkalmazása légútszűkület kezelésében | |
Ko et al. | Comparison of plate versus threaded k-wire for fixation of midshaft clavicular fractures | |
PH12020551311A1 (en) | Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine | |
EP4084783A4 (en) | PHARMACEUTICAL SOLUTION THAT FACILITATES DENTAL REMINERALIZATION AND ELIMINATES LESION PAIN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FH91 | Appointment of a representative |
Free format text: FORMER REPRESENTATIVE(S): SOMFAI ES TARSAI IPARJOGI KFT., HU Representative=s name: JGM OKTATASI ES IPARJOGI KFT., HU |
|
FH92 | Termination of representative |
Representative=s name: SOMFAI ES TARSAI IPARJOGI KFT., HU |
|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |